Engeli S et al. |
Activation of the peripheral endocannabinoid system in human obesity. |
2005 |
Diabetes |
pmid:16186383
|
Iturralde M et al. |
Characterization of the lipolytic pathways that mediate free fatty acid release during Fas/CD95-induced apoptosis. |
2005 |
Apoptosis |
pmid:16215685
|
Di S et al. |
Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. |
2005 |
J. Physiol. (Lond.) |
pmid:16239276
|
Cabranes A et al. |
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. |
2005 |
Neurobiol. Dis. |
pmid:16242629
|
Alger BE |
Endocannabinoid identification in the brain: studies of breakdown lead to breakthrough, and there may be NO hope. |
2005 |
Sci. STKE |
pmid:16278487
|
Gokoh M et al. |
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, enhances the adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes. |
2005 |
FEBS Lett. |
pmid:16288744
|
Safo PK and Regehr WG |
Endocannabinoids control the induction of cerebellar LTD. |
2005 |
Neuron |
pmid:16301180
|
Quistad GB et al. |
Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice. |
2006 |
Toxicol. Appl. Pharmacol. |
pmid:16310817
|
Suplita RL et al. |
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. |
2006 |
Neuropharmacology |
pmid:16316669
|
Juan-Picó P et al. |
Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. |
2006 |
Cell Calcium |
pmid:16321437
|
Hill MN et al. |
Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala. |
2005 |
Eur. J. Pharmacol. |
pmid:16324692
|
Panikashvili D et al. |
The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. |
2006 |
Neurobiol. Dis. |
pmid:16364651
|
Lauckner JE et al. |
The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16365309
|
Ligresti A et al. |
Endocannabinoid metabolic pathways and enzymes. |
2005 |
Curr Drug Targets CNS Neurol Disord |
pmid:16375679
|
Parkkari T et al. |
Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE). |
2006 |
Bioorg. Med. Chem. |
pmid:16403642
|
D'Argenio G et al. |
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. |
2006 |
FASEB J. |
pmid:16403786
|
Guagnini F et al. |
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P. |
2006 |
Gut |
pmid:16423891
|
Waku K |
[Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol]. |
2006 |
Yakugaku Zasshi |
pmid:16462096
|
Parkkari T et al. |
Alpha-methylated derivatives of 2-arachidonoyl glycerol: synthesis, CB1 receptor activity, and enzymatic stability. |
2006 |
Bioorg. Med. Chem. Lett. |
pmid:16466915
|
Gough NR |
Focus issue: signaling lipids. |
2006 |
Sci. STKE |
pmid:16467192
|
Sang N et al. |
PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons. |
2006 |
J. Physiol. (Lond.) |
pmid:16484297
|
Kurihara R et al. |
Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils. |
2006 |
J. Biol. Chem. |
pmid:16513651
|
Bari M et al. |
New insights into endocannabinoid degradation and its therapeutic potential. |
2006 |
Mini Rev Med Chem |
pmid:16515464
|
Mechoulam R et al. |
Endocannabinoids, feeding and suckling--from our perspective. |
2006 |
Int J Obes (Lond) |
pmid:16570101
|
Matias I et al. |
Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. |
2006 |
Int J Obes (Lond) |
pmid:16570107
|
Rockwell CE et al. |
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. |
2006 |
Mol. Pharmacol. |
pmid:16611855
|
Oka S et al. |
Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol. |
2006 |
Eur. J. Pharmacol. |
pmid:16647054
|
Yoshida T et al. |
Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. |
2006 |
J. Neurosci. |
pmid:16672646
|
Sugiura T et al. |
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2006 |
Prog. Lipid Res. |
pmid:16678907
|
Katona I et al. |
Molecular composition of the endocannabinoid system at glutamatergic synapses. |
2006 |
J. Neurosci. |
pmid:16723519
|
van der Stelt M et al. |
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. |
2006 |
Cell. Mol. Life Sci. |
pmid:16732431
|
Melis M et al. |
Protective activation of the endocannabinoid system during ischemia in dopamine neurons. |
2006 |
Neurobiol. Dis. |
pmid:16762556
|
Kishimoto S et al. |
Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants. |
2006 |
Int. Arch. Allergy Immunol. |
pmid:16772720
|
Malcher-Lopes R et al. |
Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. |
2006 |
J. Neurosci. |
pmid:16775153
|
Wagner JA et al. |
2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. |
2006 |
J. Cardiovasc. Pharmacol. |
pmid:16775503
|
Hermann A et al. |
2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook. |
2006 |
AAPS J |
pmid:16808043
|
Kasai HF et al. |
Studies on high-energy collision-induced dissociation of endogenous cannabinoids: 2-arachidonoylglycerol and n-arachidonoylethanolamide in FAB-mass spectrometry. |
2006 |
Anal Sci |
pmid:16837740
|
Mestre L et al. |
The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection. |
2006 |
Biochem. Pharmacol. |
pmid:16914119
|
Saario SM et al. |
URB754 has no effect on the hydrolysis or signaling capacity of 2-AG in the rat brain. |
2006 |
Chem. Biol. |
pmid:16931330
|
Spoto B et al. |
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol. |
2006 |
Biochimie |
pmid:16949718
|
Szabo B et al. |
Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. |
2006 |
J. Physiol. (Lond.) |
pmid:16973696
|
Parrish JC and Nichols DE |
Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism. |
2006 |
J. Neurochem. |
pmid:17010161
|
Kreutz S et al. |
Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures. |
2007 |
Exp. Neurol. |
pmid:17010339
|
Matias I et al. |
Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. |
2006 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:17011761
|
Bari M et al. |
Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells. |
2006 |
J. Immunol. |
pmid:17015679
|
Blüher M et al. |
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. |
2006 |
Diabetes |
pmid:17065342
|
Suhara Y et al. |
Synthesis and biological evaluation of several structural analogs of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2007 |
Bioorg. Med. Chem. |
pmid:17110113
|
Yu Y et al. |
Targeted cyclooxygenase gene (ptgs) exchange reveals discriminant isoform functionality. |
2007 |
J. Biol. Chem. |
pmid:17110378
|
Straiker A and Mackie K |
Metabotropic suppression of excitation in murine autaptic hippocampal neurons. |
2007 |
J. Physiol. (Lond.) |
pmid:17110416
|
Rossi G et al. |
Follicle-stimulating hormone activates fatty acid amide hydrolase by protein kinase A and aromatase-dependent pathways in mouse primary Sertoli cells. |
2007 |
Endocrinology |
pmid:17110429
|
Sarchielli P et al. |
Endocannabinoids in chronic migraine: CSF findings suggest a system failure. |
2007 |
Neuropsychopharmacology |
pmid:17119542
|
Richardson D et al. |
Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. |
2007 |
Anal. Biochem. |
pmid:17141174
|
Oka S et al. |
Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. |
2006 |
J. Immunol. |
pmid:17142782
|
Deshpande LS et al. |
Endocannabinoids block status epilepticus in cultured hippocampal neurons. |
2007 |
Eur. J. Pharmacol. |
pmid:17174949
|
Guindon J et al. |
The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors. |
2007 |
Br. J. Pharmacol. |
pmid:17179944
|
Shiga N et al. |
Elimination of 2-arachidonoylglycerol action by direct hemoperfusion through immobilized polymyxin B fibers: an experimental study in conscious guinea pigs. |
2006 |
Ther Apher Dial |
pmid:17199882
|
Scutt A and Williamson EM |
Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors. |
2007 |
Calcif. Tissue Int. |
pmid:17205329
|
Côté M et al. |
Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. |
2007 |
Int J Obes (Lond) |
pmid:17224929
|
McCarron RM et al. |
Endothelial-mediated regulation of cerebral microcirculation. |
2006 |
J. Physiol. Pharmacol. |
pmid:17244945
|
Ho WS and Randall MD |
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. |
2007 |
Br. J. Pharmacol. |
pmid:17245358
|
Palomäki VA et al. |
Visualization of 2-arachidonoylglycerol accumulation and cannabinoid CB1 receptor activity in rat brain cryosections by functional autoradiography. |
2007 |
J. Neurochem. |
pmid:17254014
|
Wang H et al. |
Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. |
2007 |
Prostaglandins Other Lipid Mediat. |
pmid:17259073
|
Coopman K et al. |
Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis. |
2007 |
Int. Immunopharmacol. |
pmid:17276894
|
Hohmann AG |
Inhibitors of monoacylglycerol lipase as novel analgesics. |
2007 |
Br. J. Pharmacol. |
pmid:17293886
|
Bátkai S et al. |
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. |
2007 |
FASEB J. |
pmid:17327359
|
DeMorrow S et al. |
Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts. |
2007 |
J. Biol. Chem. |
pmid:17329257
|
Ade KK and Lovinger DM |
Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum. |
2007 |
J. Neurosci. |
pmid:17329438
|
Oka S et al. |
Depolarization-induced rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain synaptosomes. |
2007 |
J. Biochem. |
pmid:17339228
|
Basavarajappa BS |
Critical enzymes involved in endocannabinoid metabolism. |
2007 |
Protein Pept. Lett. |
pmid:17346227
|
Muccioli GG et al. |
Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. |
2007 |
J. Neurosci. |
pmid:17360910
|
D'Argenio G et al. |
Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats. |
2007 |
J. Mol. Med. |
pmid:17396241
|
Uchigashima M et al. |
Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. |
2007 |
J. Neurosci. |
pmid:17409230
|
Ryan D et al. |
Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue. |
2007 |
Eur. J. Neurosci. |
pmid:17419758
|
Gonthier MP et al. |
Identification of endocannabinoids and related compounds in human fat cells. |
2007 |
Obesity (Silver Spring) |
pmid:17426318
|
Siegmund SV et al. |
The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. |
2007 |
FASEB J. |
pmid:17440119
|
Endsley MP et al. |
Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism. |
2007 |
Int. J. Cancer |
pmid:17443494
|
Ortar G et al. |
Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation. |
2008 |
Eur J Med Chem |
pmid:17452063
|
Sang N et al. |
COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity. |
2007 |
J. Neurochem. |
pmid:17539917
|
Soria-Gómez E et al. |
Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. |
2007 |
Br. J. Pharmacol. |
pmid:17549045
|
Karsak M et al. |
Attenuation of allergic contact dermatitis through the endocannabinoid system. |
2007 |
Science |
pmid:17556587
|
Rubio M et al. |
Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. |
2007 |
Neurosci. Lett. |
pmid:17574742
|
Labar G et al. |
Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling. |
2007 |
Chembiochem |
pmid:17579916
|
Jung KM et al. |
A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization. |
2007 |
Mol. Pharmacol. |
pmid:17584991
|
Fan SF and Yazulla S |
Retrograde endocannabinoid inhibition of goldfish retinal cones is mediated by 2-arachidonoyl glycerol. |
2007 May-Jun |
Vis. Neurosci. |
pmid:17592669
|
Williams J et al. |
Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. |
2007 |
Anal. Chem. |
pmid:17600384
|
Gokoh M et al. |
2-Arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells. |
2007 |
Biol. Pharm. Bull. |
pmid:17603153
|
Centonze D et al. |
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. |
2007 |
Brain |
pmid:17626034
|
Hashimotodani Y et al. |
Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release. |
2008 |
Neuropharmacology |
pmid:17655882
|
Mátyás F et al. |
Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. |
2008 |
Neuropharmacology |
pmid:17655884
|
Lafourcade M et al. |
Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. |
2007 |
PLoS ONE |
pmid:17684555
|
He F et al. |
Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor. |
2007 |
Mol. Pharmacol. |
pmid:17698952
|
Tam J et al. |
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. |
2008 |
FASEB J. |
pmid:17704191
|
Chiu CQ and Castillo PE |
Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus. |
2008 |
Neuropharmacology |
pmid:17706254
|
Smid SD et al. |
The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon. |
2007 |
Eur. J. Pharmacol. |
pmid:17706636
|
Moreira FA et al. |
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. |
2008 |
Neuropharmacology |
pmid:17709120
|
Saario SM and Laitinen JT |
Monoglyceride lipase as an enzyme hydrolyzing 2-arachidonoylglycerol. |
2007 |
Chem. Biodivers. |
pmid:17712832
|
Sugiura T |
[2-Arachidonoylglycerol: an endogenous cannabinoid receptor ligand]. |
2007 |
Seikagaku |
pmid:17763698
|
Cisneros JA et al. |
Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase. |
2007 |
J. Med. Chem. |
pmid:17764163
|
Vadivel SK et al. |
Conformationally constrained analogues of 2-arachidonoylglycerol. |
2007 |
Bioorg. Med. Chem. Lett. |
pmid:17826996
|
Degn M et al. |
Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice. |
2007 |
J. Neurochem. |
pmid:17868306
|